'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'.

Swayamjeet SatapathyBhagwant Rai MittalAnil Bhansali

Published in: Clinical endocrinology (2019)

Peptide receptor radionuclide therapy is a safe and efficacious treatment option for advanced PPGLs and may be considered a viable alternative to chemotherapy and I-131 MIBG.

Keyphrases

stem cells
squamous cell carcinoma
locally advanced
combination therapy
replacement therapy